US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID

Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...

from NDTV News - Latest https://ift.tt/3hX2lsF
via IFTTT

Comments

Popular posts from this blog

Ballerina Trailer: Ana de Armas And John Wick Strike A Chord Of Revenge In A Battle Of Skill And Survival

Manoj Pahwa On Working With Aryan Khan In Stardom: "He Is Similar To SRK, Takes Care Of Everyone"